A single injection begins reducing itch within 1 day and continues working for a full month

OVER 80% OF DOGS HAD SUCCESSFUL PRURITUS REDUCTION AT DAY 3

At day 3, greater than 80% of dogs administered Canine Atopic Dermatitis lmmunotherapeutic* achieved treatment success, predefined as owner-assessed ≥20mm reduction in pruritus as scored on the pruritus Visual Analog Scale (VAS).^1†

Mean pruritus scores were very mild to mild starting at day 1 and continuing for a full month

At day 42, owner assessment of pruritus VAS scores remained mild at 37.6 mm (mean baseline, 71.0 mm) for dogs receiving a 2 mg/kg dose of Canine Atopic Dermatitis Immunotherapeutic.^1*

Skin condition begins to improve within 7 days

SKIN CONDITION SCORE REDUCTION WAS SIGNIFICANT AT DAY 14

Significantly more dogs treated with Canine Atopic Dermatitis Immunotherapeutic achieved treatment success (at least a 50% reduction from baseline in CADESI-03) compared to dogs treated with placebo from day 14 of the study.

Skin condition score reduction was maintained through day 28

Significant improvement in skin condition was noted at the first visit on day 7 (p≤0.05). At day 28, there was a nearly 50% decrease in mean CADESI-03 scores for dogs administered Canine Atopic Dermatitis Immunotherapeutic* (73.7) compared to dogs administered placebo (121.9) (mean baseline for all dogs, 153.9).¹